Next Article in Journal
Response to “Adenocarcinoma Not otherwise Specified or Cribriform Adenocarcinoma on Dorsum of Tongue?”
Previous Article in Journal
Adenocarcinoma not Otherwise Specified or Cribriform Adenocarcinoma on Dorsum of Tongue?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 20
Issue 6
10.3747/co.20.1598
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Letter

Weakly Hormone Receptor–Positive Breast Cancer and Use of Adjuvant Hormonal Therapy

by
Cassandra M. Lin
1,
Jasbir Jaswal
1,
Theodore Vandenberg
2,
Alan Tuck
1,2 and
Muriel Brackstone
2,*
1
Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada
2
Univ Western Ontario, Dept Pathol, London, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2013, 20(6), 612-613; https://doi.org/10.3747/co.20.1598
Submission received: 8 September 2013 / Revised: 10 October 2013 / Accepted: 8 November 2013 / Published: 1 December 2013

Abstract

Breast cancer is the most common cancer affecting women1, and estrogen receptor (ER)–positive breast cancer is the most common subtype2.

Share and Cite

MDPI and ACS Style

Lin, C.M.; Jaswal, J.; Vandenberg, T.; Tuck, A.; Brackstone, M. Weakly Hormone Receptor–Positive Breast Cancer and Use of Adjuvant Hormonal Therapy. Curr. Oncol. 2013, 20, 612-613. https://doi.org/10.3747/co.20.1598

AMA Style

Lin CM, Jaswal J, Vandenberg T, Tuck A, Brackstone M. Weakly Hormone Receptor–Positive Breast Cancer and Use of Adjuvant Hormonal Therapy. Current Oncology. 2013; 20(6):612-613. https://doi.org/10.3747/co.20.1598

Chicago/Turabian Style

Lin, Cassandra M., Jasbir Jaswal, Theodore Vandenberg, Alan Tuck, and Muriel Brackstone. 2013. "Weakly Hormone Receptor–Positive Breast Cancer and Use of Adjuvant Hormonal Therapy" Current Oncology 20, no. 6: 612-613. https://doi.org/10.3747/co.20.1598

APA Style

Lin, C. M., Jaswal, J., Vandenberg, T., Tuck, A., & Brackstone, M. (2013). Weakly Hormone Receptor–Positive Breast Cancer and Use of Adjuvant Hormonal Therapy. Current Oncology, 20(6), 612-613. https://doi.org/10.3747/co.20.1598

Article Metrics

Back to TopTop